The role of genetic and autoimmune factors in premature ovarian failure

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 5, 2013, Pages 617-622

  Shamilova, Nigyar N ^a   Marchenko, Larisa A ^a   Dolgushina, Nataliya V ^a   Zaletaev, Dmitry V ^b   Sukhikh, Gennady T ^a  

^a RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Anti Mullerian hormone (AMH); Anti ovarian antibodies; CGG nucleotide repeats; FMR1 (fragile mental retardation) gene of fragile X chromosome; Premature ovarian failure (POF)

Indexed keywords

FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; MUELLERIAN INHIBITING FACTOR; SEX HORMONE; TESTOSTERONE;

ALLELE; ARTICLE; AUTOIMMUNITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; OVARIAN RESERVE; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; X CHROMOSOME INACTIVATION;

ADULT; ALLELES; AUTOANTIBODIES; AUTOIMMUNITY; CROSS-SECTIONAL STUDIES; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFERTILITY, FEMALE; OVARY; PRIMARY OVARIAN INSUFFICIENCY; RISK FACTORS; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84878600205     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-9974-4     Document Type: Article

References (22)

1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet. 1992;51:1229-39.
2. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22(8):2142-52.
3. Ashrafi M, Fallahian M, Eshrati M, Yazdi RS. The Presence of Anti Thyroid and Anti Ovarian Auto-Antibodies in Familial Premature Ovarian Failure. Int J Fertil Steril. 2008;1(4):171-4.
4. Chen LS, Tassone F, Sahota P, Hagerman PJ. The CGG repeat element within the 5′ untranslated region of the FMR1 message provides both positive and negative effects on in vivo translation of a downstream reporter. Hum Mol Genet. 2003;12(23):3067-74.
5. Conway GS, Katlas G, Patel A, Davies MS, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996;65(2):337-41.
6. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod. 1998;13(5):1184-7.
7. Coulam CB, Ryan RJ. Premature menopause.I. Etiology. Am J Obstet Gynecol. 1979;133(6):639-43.
8. Fenishel P, Sosset C, Barbarino-Monnier P, Gobert B, Hieronimus S, Bene MC, et al. Prevalence, specificity and significance of antiovarian antibodies during spontaneous premature ovarian failure. Hum Reproad. 1997;12(12):2623-8.
9. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67(6):1047-58.
10. Gleicher N, Weghofer A, Barad D. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011;9:23.
11. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing. Reprod Biomed Online. 2010;20(6):768-75.
12. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online. 2009;19(3):385-90.
13. Gleicher N, Weghofer A, Oktay K, Barad DH. Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging? Menopause. 2009;16(4):760-4.
14. La Marka A, Marzotti S, Bronzetti A, Stabile G, Artenisio AC, Bini V, et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J Clin Endocrinol Metab. 2009;94(10):3816-23.
15. Sato K, Uehara S, Hashiyada M, Nabeshima H, Sugawara J, Terada Y, et al. Genetic significance of skewed X-chromosome inactivation in premature ovarian failure. Am J Med Genet. 2004;130A(3):240-4.
16. Shamilova NN, Marchenko LA, Shamilova NN, Marchenko LA. The FMR1 gene: new possibilities of assessing the ovarian reserve. Akusherstvo & Gynecologiya. 2011;2:58-64. article in Russian.
17. Sugawa F, Wada Y, Maruyama T, Uchida H, Ishizuka B, Ogata T. Premature ovarian failure and androgen receptor gene CAG repeat lengths weighted by X chromosome inactivation patterns. Fertil Steril. 2009;91(2):649-52.
18. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402-12.
19. Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P, et al. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocrinol Metab. 2008;93(4):1263-9.
20. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68(4):499-509.
21. Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP. Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod. 1997;12(12):2617-22.
22. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87(3):456-65.